News & Analysis on Clinical Trial Services & Contract Research And Development
A new trial model is needed to encourage cardiovascular disease drug development say researchers who claim the large, lengthly studies used to prove safety and efficacy of such drugs are a disincentive.
Dispatches from DIA 2015
CRO Pharmaceutical Product Development (PPD) has established a five-year partnership with Anthem subsidiary HealthCore to help sponsors more quickly and effectively demonstrate how their products will perform in the real world.
Health Canada has issued Hospira with an import ban over concerns about a testing lab at its manufacturing facility in Liscate, Italy.
Delivery device maker Biocorp has announced plans to go public and list of Paris’ Alternext market as part of an effort to win more Big Pharma deals.
update
Trade secrets proposals supported by the European Parliament’s legal affairs committee could allow drugmakers to withhold trial results and drug safety data says Health Action International.
Debiopharm has acquired Spinomix's FibroTrap sample processing technology for an undisclosed sum.
Dispatches from DIA 2015
Competition among the top CROs, many of which are conglomerations of smaller peers, is “ferocious” right now on nearly every level, Parexel CEO Josef von Rickenbach told Outsourcing-Pharma.com at the 51st annual DIA conference.